Scaling Health and Longevity Conference
2026 Agenda
- The 2026 Agenda
FILTERS
Stages
Experience
Type
The Foundations of Longevity
Registration & Refreshments
The Rails Beneath the Revolution: How Longevity Actually Scales
Longevity has never had more attention, yet most clinics and vendors are struggling to fill chairs. The space looks like a boom, but the boom is in supply, not in working demand. Thousands of providers, vendors, and doctors are now competing for the same individual cash-paying consumer, inside a market that is fragmented, hard to access, and missing the standards and education that large-scale adoption requires.
This opening keynote reframes the challenge every longevity business is facing. The bottleneck is not consumer interest. It is fragmentation, scalability, and trust. Jonathan Edelheit looks at why market confusion and a lack of education freeze buyers, why the race to differentiate is a symptom rather than a cure, and why the biggest growth ahead lies with enterprise: employers, corporations, insurance companies, and banks. He explains why the market has not yet been built to serve those clients, and how the businesses that solve it will grow fast in the decade ahead.
Longevity Beyond Wellness and Medicine
To reveal how cultural attitudes toward longevity shape public expectations and present new research on these perceptions, inviting delegates to contribute live to an ongoing study.
Blueprint for a Longevity Health System
As populations age, most health systems are still built to treat sickness not protect health. This session explores how to redesign care models around early screening, multi‑generational prevention and long term support from prenatal years through to end of life. Leaders from public systems, private providers and insurers will share practical blueprints for shifting resources upstream, integrating data and aligning incentives so that staying healthy becomes the core business of healthcare.
Morning Networking Break
Making Prevention Pay
As prevention and early intervention move centre stage, organisations are under pressure to make them both clinically effective and financially sustainable. This session explores how clinics, insurers and employers are redesigning products, incentives and service models to monetise better long‑term health, align economics with prevention, and capture value through reduced risk, improved productivity and stronger member or employee engagement.
GLP-1s and The Future of Preventive Longevity Medicine
GLP‑1 drugs have surged as weight‑loss treatments, but their broader impact on metabolic health, cardiovascular risk and system-wide costs is still emerging. This session explores what GLP‑1s agonists could mean for clinical practice, insurers, employers and consumers, and how these therapies might fit into wider prevention and care strategies as evidence and appetite builds.
Networking Lunch
Designing the Longevity Economy
As people live longer, traditional models of insurance, pensions and savings face growing strain and no longer map neatly onto extended working lives. This session examines how financial institutions, insurers and policymakers are rethinking risk, product design and incentives to better align money, work and retirement with longer lifespans, exploring innovations that can support financial security, flexibility and resilience across a much longer life course.
Roundtable Discussions
Preventative Health: Why Is It Not Done Properly?
Is Longevity the Key to Reduce Inequalities?
The Longevity Economy as a New Model for Healthcare
From One-to-One to One-to-Many: Scaling Personalised Care Through Content and Community
Lessons in Scaling: Hiring and Retaining Great Talent
Sustaining Performance: Why High Performers Ignore the Signals That Matter Most
The ‘Female Physiology First’ Stance: Performance Meets Female Physiology
Afternoon Networking Break
The Gender Gap in Longevity
Health systems have historically under‑served both women and men in different ways, from research gaps and underrepresentation in clinical trials to overlooked life stages such as menopause and andropause. This session explores how these biases shape health outcomes across the lifespan and considers what true “longevity equality” should look like in clinics, workplaces and policy, highlighting practical changes that can better support both sexes throughout longer, healthier lives.
Final Round of Pitch Competition
1.Anyo Labs 2.Enbiosis Biotechnology 3.OvartiX 4.The Protein Brewery 5. Zuri Health
Guardrails to Guidance
AI is rapidly evolving from basic decision-support and triage tools to systems capable of synthesising complex clinical, imaging and genomic data to recommend personalised care pathways. This session examines how AI may shift from acting as a guardrail to informing and potentially driving prescriptions in clinical practice, and explores the implications for regulation, liability and professional accountability, including how clinicians, health systems and technology companies can share responsibility for decisions made with machines in the loop.
Pitch Competition Winner Announced
